Metastatic Breast Cancer:
Hertraz is indicated for the treatment of adult patients with HER2 positive metastatic cancer (MBC).
Early Breast Cancer:
Hertraz is indicated for the treatment of adult patients with HER2 positive early breast cancer (EBC).
Metastatic Gastric Cancer:
Hertraz in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of adult patients with HER2 positive metastatic adenocarcinoma of stomach or gastroesophageal junction who have not received prior anti-cancer treatment for their metastatic disease.
|